CDD-2789
CDD-2789 is a highly selective small-molecule inhibitor targeting Activin receptor type 1 (ALK2, also known as ACVR1) . It blocks the SMAD1/5 signaling pathway mediated by ALK2/ALK1, thereby effectively suppressing downstream phosphorylation events induced by BMP and activin A. In the NanoBRET cellular model, CDD-2789 exhibits an inhibitory IC50 of 0.54 µM against ALK2. CDD-2789 holds promise for research on ALK2-related diseases, including diffuse intrinsic pontine glioma (DIPG), ependymoma, endometrial cancer, melanoma, non–small cell lung cancer, colorectal cancer, and pancreatic cancer[1].
Product Specifications
CAS Number
3052084-77-9
UNSPSC
12352005
Target
Anaplastic lymphoma kinase (ALK) ; TGF-beta/Smad; TGF-β Receptor
Related Pathways
Protein Tyrosine Kinase/RTK; Stem Cell/Wnt; TGF-beta/Smad
Field of Research
Cancer
Smiles
COC1=C(OC)C=C(C2=NC(C=CC(C(NCCCN(C)C)=O)=C3)=C3N2C4CCC4)C=C1OC
Molecular Formula
C26H34N4O4
Molecular Weight
466.57
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![DOT1L Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI1F1D4]](https://cdn.genprice.uk/products/937/68dd1b78061270361ea1b31a/imageurl/ta802742bm.webp)
DOT1L Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI1F1D4]
P70 S6 Kinase beta (RPS6KB2) Human Knockdown Lysate
Prothymosin, alpha (PTMA) (103-111) Rabbit Polyclonal Antibody
MCM7 (Proliferation Marker) (rMCM7/1468), 1mg/mL
